Acute promyelocytic leukemia; Early diagnosis is the key to survival

American Journal of Emergency Medicine

Volumn 31, Issue 8, 2013, Pages 1290.e1-1290.e2

  Roldan, Carlos J ^a,b   Haq, Samir M ^a,b   Miller, Adam H ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RETINOIC ACID;

ADULT; ANEMIA; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; EARLY DIAGNOSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG HEMORRHAGE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THROMBOCYTOPENIA;

EID: 84881188537     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2013.03.038     Document Type: Article

References (13)

1. J.D. Rowley, H.M. Golomb, and C. Dougherty 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia Lancet 1 1977 549 550
2. L. Hillestad Acute promyelocytic leukemia Acta Med Scand 159 1957 189 194
3. J.F. Yamamoto, and M.T. Goodman Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002 Cancer Causes Control 19 2008 379 390
4. M. Vickers, G. Jackson, and P. Taylor The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation Leukemia 14 2000 722 726
5. S.M. Gomez, V. Schuttenberg, and H. Armendariz Childhood acute leukemia: a single institution experience in La Plata, Argentina Med Pediatr Oncol 36 2001 383 385
6. J.H. Park, B. Qiao, and K.S. Panageas Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid Blood 118 2011 1248 1254
7. G. Mann, D. Reinhardt, and J. Ritter Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children Ann Hematol 80 2001 417 422
8. M. Carter, D.K. Kalwinsky, and G.V. Dahl Childhood acute promyelocytic leukemia: a rare variant of nonlymphoid leukemia with distinctive clinical and biologic features Leukemia 3 1989 298 302
9. M.A. Sanz, F. Lo Coco, and G. Martin Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups Blood 96 2000 1247 1253
10. M.A. Sanz, D. Grimwade, and M.S. Tallman Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Blood 113 2009 1875 1891
11. P. Fenaux, M.C. Le Deley, and S. Castaigne Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group Blood 82 1993 3241 3249
12. M.S. Tallman, C. Nabhan, and J.H. Feusner Acute promyelocytic leukemia: evolving therapeutic strategies Blood 99 2002 759 767
13. Z.Y. Wang, and Z. Chen Acute promyelocytic leukemia: from highly fatal to highly curable Blood 111 2008 2505 2515